Enhancer RNA Transcription Is Essential for a Novel CSF1 Enhancer in Triple-Negative Breast Cancer
Enhancers are critical regulatory elements in the genome that help orchestrate spatiotemporal patterns of gene expression during development and normal physiology. In cancer, enhancers are often rewired by various genetic and epigenetic mechanisms for the activation of oncogenes that lead to initiat...
Main Authors: | Michael W. Lewis, Kamila Wisniewska, Caitlin M. King, Shen Li, Alisha Coffey, Michael R. Kelly, Matthew J. Regner, Hector L. Franco |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-04-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/7/1852 |
Similar Items
-
Synthetic CRISPR/dCas9-KRAB system driven by specific PSA promoter suppresses malignant biological behavior of prostate cancer cells through negative feedback inhibition of PSA expression
by: Yi Yang, et al.
Published: (2023-11-01) -
Targeting Telomeres and Telomerase: Studies in Aging and Disease Utilizing CRISPR/Cas9 Technology
by: Andrew C. Brane, et al.
Published: (2019-02-01) -
CRISPR/dCas9-KRAB-Mediated Suppression of <i>S100b</i> Restores p53-Mediated Apoptosis in Melanoma Cells
by: Samrat Roy Choudhury, et al.
Published: (2023-02-01) -
Targeted Modulation of Chicken Genes In Vitro Using CRISPRa and CRISPRi Toolkit
by: Brittany Chapman, et al.
Published: (2023-04-01) -
CRISPR/Cas Derivatives as Novel Gene Modulating Tools: Possibilities and In Vivo Applications
by: Xingbo Xu, et al.
Published: (2020-04-01)